Prognostic significance of hemoglobin levels in patients with heart failure;Significado pronóstico de los valores de hemoglobina en pacientes con insuficiencia cardíaca

Revista Espanola de Cardiologia

Volumn 58, Issue 1, 2005, Pages 48-53

  Lupón, Josep ^a   Urrutia, Agustín ^a   González, Beatriz ^a   Herreros, Juan ^a   Altimir, Salvador ^a   Coll, Ramon ^a   Prats, Montserrat ^a   Rey Joly, Celestino ^a   Valle, Vicente ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Anemia; Heart failure; Hemoglobin; Survival

Indexed keywords

ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIURETIC AGENT; ENDOTHELIN CONVERTING ENZYME INHIBITOR; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC ACID DERIVATIVE; SPIRONOLACTONE;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HEART FAILURE; HEMOGLOBIN DETERMINATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREVALENCE; PROGNOSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

EID: 14944387066     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13070508     Document Type: Article

References (20)

1. Komajda M. Prevalence of anemia in patients with chronic heart failure and their clinical characteristics. J Card Fail. 2004;10:S1-4.
2. Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol. 2000;35:1737-44.
3. Tanner H, Moschovitis G, Kuster GM, Hullin R, Pfiffner D, Hess OM, et al. The prevalence of anemia in chronic heart failure. Int J Cardiol. 2002;86:115-21.
4. Ezekowitz JA, McAlister FA, Amstrong PW. Anemia is common in heart failure and is associated with poor outcomes. Insights from a cohort of 12065 patients with new-onset heart failure. Circulation. 2003;107:223-5.
5. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002;39:1780-6.
6. Androne AS, Katz SD, Lund L, LaManca J, Hudaihed A, Hryniewicz K, et al. Hemodilution is common in patients with advanced heart failure. Circulation. 2003;107:226-9.
7. Kosiborod M, Smith G, Radford M, Foody J, Krumholz H. The prognostic importance of anemia in patients with heart failure. Am J Med. 2003;114:112-9.
8. Mozaffarian D, Nye R, Levy C. Anemia predicts mortality in severe heart failure. J Am Coll Cardiol. 2003;41:133-9.
9. Felker GM, Gattis W, Leimberguer J, Adams K, Cuffe M, Gheorghiade M, et al. Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. Am J Cardiol. 2003;92:625-8.
10. McMurray JJV. What are the clinical consequences of anemia in patients with chronic heart failure? J Card Fail. 2004;10:S10-2.
11. Parsi A, Kleber FX. Anaemia in heart failure: its diagnosis and management. Eur J Heart Fail. 2003;5:3-4.
12. Chatterjee B, Nydegger UE, Mohacsi P. Serum erythropoietin in heart failure patients treated with ACE-inhibitors or AT(1) antagonists. Eur J Heart Fail. 2000;2:393-8.
13. Silveberg DS, Wexler D, Iaina A. The importance of anaemia and its correction in the management of severe congestive heart failure. Eur J Heart Fail. 2002;4:681-6.
14. Okonko D, Ander S. Anemia in chronic heart failure: pathogenetic mechanisms. J Card Fail. 2004;10:S5-9.
15. Urrutia A, Lupón J, González B, Parajón T, Altimit S, Coll R, et al. Anemia y parámetros relacionados en pacientes de una unidad de insuficiencia cardíaca multidisciplinaria. Med Clin (Barc). 2004;122:121-5.
16. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. Am J Kidney Dis. 1977;30:S193-240.
17. Levy D, Kenchaiah S, Larson M, Benjamin EJ, Kupka MJ, Ho KK, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347;1397-402.
18. Silverberg DS, Wexler D, Sheps D, Blum M, Karen G, Baruch R, et al. The effect of correction of mild anaemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomised controlled study. J Am Coll Cardiol 2001;37:1775-80.
19. Silveberg DS, Wexler D, Blum M, Tchebiner JZ, Sheps D, Keren G, et al. The effect of correction of anemia in diabetics and nondiabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. Nephrol Dial Transplant. 2003;18:141-6.
20. Mancini D, Katz S, Lang C, LaManca J, Hudauhed A, Androne AS. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation. 2003;107; 294-9.